Cerus Corporation (CERS) Earnings Per Share (EPS)
Cerus Corporation (CERS) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | -$0.62 |
| 2017-12-31 | -$0.56 |
| 2018-12-31 | -$0.44 |
| 2019-12-31 | -$0.51 |
| 2020-12-31 | -$0.37 |
| 2021-12-31 | -$0.32 |
| 2022-12-31 | -$0.24 |
| 2023-12-31 | -$0.21 |
| 2024-12-31 | -$0.11 |
| 2025-12-31 | -$0.08 |
How CERS compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| AKBA | Akebia Therapeutics Inc. | -$0.02 |
| NEOG | Neogen Corporation | -$0.04 |
| TXMD | TherapeuticsMD Inc. | -$0.05 |
| HRTX | Heron Therapeutics Inc. | -$0.12 |
| LXRX | Lexicon Pharmaceuticals Inc. | -$0.14 |
These are five companies in the same sector as CERS with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Cerus Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("CERS")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CERS | $2.52 | +7.23% | 2.73M |
| 3 | ||||
| 4 | ||||
| 5 |